The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cho, S.-H.
Right arrow Articles by Kim, J.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, S.-H.
Right arrow Articles by Kim, J.-H.
The Journal of Immunology, 2004, 173: 624-631.
Copyright © 2004 by The American Association of Immunologists

Rac and Protein Kinase C-{delta} Regulate ERKs and Cytosolic Phospholipase A2 in Fc{epsilon}RI Signaling to Cysteinyl Leukotriene Synthesis in Mast Cells1

Sung-Hoon Cho*,{dagger}, Hye-Jin You*,{dagger}, Chang-Hoon Woo*, Yung-Joon Yoo{dagger} and Jae-Hong Kim2,*

* School of Life Sciences and Biotechnology, Korea University, Seoul, Korea; and {dagger} Department of Life Science, Gwangju Institute of Science and Technology, Gwangju, Korea

Although cysteinyl leukotrienes (cysLTs) are known to be principal inflammatory lipid mediators released from IgE-stimulated mast cells, the signaling mechanisms involved in the synthesis of cysLTs remain largely unknown. In the present study, therefore, we investigated the signaling pathway by which IgE induces cysLTs synthesis after binding to its high affinity receptor (Fc{epsilon}RI) in RBL-2H3 mast cells. We found that IgE-induced cysLT synthesis is completely abolished in RBL-2H3Rac-N17 cells, a stable cell line expressing RacN17, a dominant negative Rac1 mutant; conversely, synthesis was enhanced in cells expressing RacV12, a constitutively active Rac1 mutant, suggesting that Rac1 is a key mediator of IgE signaling to cysLT synthesis. Further analysis aimed at identifying mediators downstream of Rac1 revealed that pretreating cells with a protein kinase C-{delta} (PKC-{delta}) inhibitor or infection with an adenoviral vector harboring a dominant negative PKC-{delta} mutant significantly attenuates IgE-induced ERKs phosphorylation, cytosolic phospholipase A2 phosphorylation/translocation, and cysLT synthesis. In addition, the expression of RacN17 blocked PKC-{delta} translocation and impaired the phosphorylation of ERKs and cytosolic phospholipase A2 otherwise elicited by IgE stimulation. Taken together these results suggest that PKC-{delta} also plays a critical mediatory role in the IgE signaling pathway leading to cysLT synthesis, acting downstream of Rac1. Finally, the physiological significance of PKC-{delta} in the IgE signaling pathway was demonstrated in an Ag (OVA)-challenged in vivo mouse model, in which induced levels of cysLTs and airway responsiveness in lung airways were significantly diminished by prior i.p. injection of a PKC-{delta} inhibitor.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. S. Kuehn, E. J. Swindle, M.-S. Kim, M. A. Beaven, D. D. Metcalfe, and A. M. Gilfillan
The Phosphoinositide 3-Kinase-Dependent Activation of Btk Is Required for Optimal Eicosanoid Production and Generation of Reactive Oxygen Species in Antigen-Stimulated Mast Cells
J. Immunol., December 1, 2008; 181(11): 7706 - 7712.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. P. Hurley and B. A. McCormick
Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation
Infect. Immun., June 1, 2008; 76(6): 2259 - 2272.
[Full Text] [PDF]


Home page
J. Immunol.Home page
N. Kato, M. Nakanishi, and N. Hirashima
Flotillin-1 Regulates IgE Receptor-Mediated Signaling in Rat Basophilic Leukemia (RBL-2H3) Cells
J. Immunol., July 1, 2006; 177(1): 147 - 154.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.